Status:
COMPLETED
Comparison of Probiotic Effects on the Outcomes of Patients After Colorectal Cancer Surgery
Lead Sponsor:
Dharmais National Cancer Center Hospital
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
This clinical trial aims to compare the effects of administering Lactobacillus casei Shirota probiotics with Lactobacillus acidophilus on the outcomes of patients after colorectal cancer surgery. Rese...
Detailed Description
The research design was a two-group unblinded, randomized clinical trial in 90 adult patients undergoing colorectal cancer surgery who are treated in the ICU, HCU and wards of Dharmais Cancer Hospital...
Eligibility Criteria
Inclusion
- 1\. Patients who were diagnosed with colorectal cancer and would undergo resection surgery at Dharmais Cancer Hospital
Exclusion
- The patient or patient's family refused to be included in the study
- Patients with chronic diseases such as HIV, uncontrolled diabetes mellitus (, uncontrolled cardiovascular disease and kidney failure
- Patients with a history of regular probiotics, or steroids, or antibiotics consumption
- Patients with anatomical disorders of the gastrointestinal system
- Patients with immunocompromised conditions.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 4 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT07144475
Start Date
January 1 2024
End Date
March 4 2025
Last Update
August 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, University of Indonesia
Jakarta, DKI Jakarta, Indonesia, 10430